Skip to main content
Clinical Trials/NL-OMON42396
NL-OMON42396
Completed
N/A

Contrast enhanced ultrasound to measure cerebral blood flow - Contrast enhanced ultrasound to measure cerebral blood flow

niversitair Medisch Centrum Sint Radboud0 sites10 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
acute brain injury
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • Healthy men or women of 18\-35 years old

Exclusion Criteria

  • Hypersensitivity to the active substance(s) or to any of the excipients in SonoVue
  • Right\-to\-left shunt cardiac shunt
  • Severe pulmonary hypertension (pulmonary artery pressure \>90 mmHg)
  • Uncontrolled systemic hypertension
  • Participation in another clinical trial within 3 months prior to the experimental day.
  • History, signs, or symptoms of cardiovascular disease or pulmonary disease
  • History, signs or symptoms of neurological disease
  • History of hyperventilation

Outcomes

Primary Outcomes

Not specified

Similar Trials